Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aceclofenac
A A H Pharmaceuticals Ltd
M01AB16
Aceclofenac
100mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5025903006701
PRESERVEX ® TABLETS ACECLOFENAC 100MG TABLETS (aceclofenac) PATIENT INFORMATION LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor , pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. Your medicine is available using any one of the above names but will be referred to as Preservex throughout the following leaflet. WHAT IS IN THIS LEAFLET: 1. What Preservex is and what it is used for 2. What you need to know before you take Preservex 3. How to take Preservex 4. Possible side effects 5. How to store Preservex 6. Contents of the pack and other information 1. WHAT PRESERVEX IS AND WHAT IT IS USED FOR Preservex belongs to a group of medicines called non-steroidal anti- inflammatory drugs (NSAIDs). They have anti-inflammatory and painkiller properties causing a lowering of swelling, redness (inflammation) and pain. The medicine/active ingredient of Preservex is aceclofenac. Preservex works by blocking the production of hormone-like substances called prostaglandins. Prostaglandins have many functions in the body including an important role in both the way the body responds to inflammation and also the reabsorption of calcium in some diseases of the bone. Preservex is used to relieve pain and reduce redness and swelling (inflammation) in patients suffering from: - Osteoarthritis - inflammation of the joints. This is a common condition in patients over the age of 50 and causes damage to the tissues and bones in the joints. - Rheumatoid arthritis - long term inflammation of the joints caused by the body’s own immune system (autoimmune response). - Ankylosing spondylit Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Aceclofenac 100 mg Film-coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 100 mg aceclofenac. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Round white or off-white in colour bi-convex film-coated tablets marked “G” on one side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Aceclofenac is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults: The maximum recommended dose is 200 mg daily, taken as two separate doses of 100 mg, one tablet in the morning and one tablet in the evening. Children: There are no clinical data supporting the use of aceclofenac in children therefore its use is not recommended. Elderly: Caution should be exercised in the treatment of elderly patients, who are generally more prone to adverse reactions, and who are more likely to be suffering from impaired renal, cardiovascular or hepatic function and receiving concomitant medication. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The elderly should be monitored for GI bleeding regularly during NSAID therapy. The pharmacokinetics of aceclofenac are not altered in elderly patients, therefore it is not considered necessary to modify the dose or dose frequency. Renal insufficiency: There is no evidence to suggest that the dosage needs to be altered for patients with mild renal impairment, however caution should be exercised (see section 4.4). Hepatic insufficiency: There is some evidence that the dose of aceclofenac should be reduced in patients with hepatic impairment. It is suggested that an initial daily dose of 100 mg is used. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). Method of administration: For Read the complete document